Their high-protein, low-carb profile helps regulate blood sugar levels throughout the day
244 Conversely, the expression level of GLP-1R on -cells is relatively high
The Regulatory Landscape: What You Should Know The FDA's position on peptides has evolved
Digestive/GI side effects are common: nausea, vomiting, diarrhea, constipation, delayed gastric emptying (gastroparesis) have all been documented
Patients with T2D are considered for CVD secondary prevention because their risk level is similar to that reported in nondiabetic patients who have already suffered a MI [3]
Patients and providers must prioritize safety, monitor for adverse events, and report concerns to the FDA. So how do you know which one you have